U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further ...

Michael Castagna became CEO of MannKind and joined its board of directors in 2017, bringing 25+ years’ experience in ...

Amgen and CytomX Therapeutics have kicked a phase 1 T-cell engager to the curb, axing the asset after assessing the clinical ...

Much like the straightened origins of Apple or Microsoft, Amgen combined a relaxed attitude with determination and flexibility in dealing with limited resources. The CEO’s office was housed in a ...

Amgen has made a play in a hot area of immunology ... promising late-stage asset to treat atopic dermatitis," said Amgen CEO Robert Bradway. "We will take advantage of our two decades of ...

Hyderabad: US-based biopharma giant Amgen flagged off its first India investment with a new technology and innovation centre in Hyderabad.

Amgen and Ideaya Biosciences are winding down ... The biotech unveiled IDE892 at an R&D event in December. At the event, Ideaya CEO Yujiro Hata hailed the drug candidate as a potential best ...

U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further investments planned, Chief Executive Officer Robert Bradway said at the ...